CIDPUSA.ORG

Home
Diagnosis
Treatment
Pathology
SLE
Mammogram
Fibromyalgia
IVIG
Anti-inflammatory Diet
Burning  Feet Home
Services Page
Chronic Fatigue
Autoimmune diseases
Miss cidpusa page
Bible healing
Celiac disease

CIDP Tips

AMYTOPHIC LATERAL SCLEROSIS

 Scleroderma

Multiple Sclerosis treatment

Morgellons story

CoEnzymeQ10

Graves disease

Morgellons Syndrome

 

Cancer and Bacteria

 

CMT

Miracle ITP

Cholesterol drugs & Bleeding

Cocunut oil

   Pregnant Vaccine

   ORGANIC CERTIFIED

Broccoli & Prostate Genes

Green TEA AND HEART DISEASE

Walnut oil

Cell death

Blood injection saves

 Natural Makeup

Gout & Garlic

 

 

.

SpecialGoogleHealth Search
Alternative medical treatments read our e-book 
PM/DM and viruses
Scientists have strong evidence that the Coxsackie B virus plays a role in the onset of PM/DM. This was demonstrated by tracing antibodies in the serum and by tracing the virus in the muscle tissue. Other viruses are also suspect.
Drug-induced PM/DM
This type is very rare.
About twenty cases have been reported after they had taken D-Penicillamine. When the treatment with this drug is discontinued, the symptoms disappear. Other cases after administration of cimetidine, penicillin, procainamide, hydralazine and propylthiouracil have been reported.
Syndromes similar to PM/DM were seen after patients had taken drugs to lower the cholesterol level with statin.

PM/DM and other diseases
PM/DM can occur as a part of other connective tissue diseases. Also other autoimmune diseases like Hashimoto thyroiditis (autoimmune inflammation of the thyroid gland) and pemphigus (autoimmune skin disease) may occur together with PM/DM.
Localised PM
PM only rarely involves just one muscle or muscle group, but it is possible that e.g. only one limb is inflamed.
Diagnosis
There is no single diagnostic test for PM/DM.
The diagnosis is made when there are sufficient symptoms of the disease present. These are:
 
  • Typical symptoms at the level of the shoulders and/or pelvic muscles with distinctive skin manifestations
  • Signs of inflammation and muscle necrosis on a muscle biopsy
  • Increased amount of muscle enzymes in the serum
  • Signs of muscle damage or damage to nerve ends on an electromyography
If two of these criteria are satisfied, it is possible to make a diagnosis, but none of the criteria (not even the increase of muscle enzymes) are necessary to be able to make a diagnosis.


Autoantibodies
Antinuclear antibodies are present in 67 % of the patients. Detailed tests sometimes show antibodies against a specific nucleus or cytoplasmatic (cytoplasm = part of the cell outside the nucleus, but inside the cell wall) antigens, namely PM1 (30 to 50% in PM, 5 to 10% in DM), Mi2 (5 to 10% in DM), Jo1 (10 to 30% in PM, especially with lung damage). These antibodies are a diagnostic aid but it does not imply that if they are not present, the diagnosis of the disease cannot be made.
Treatment
In acute PM/DM with severe complaints, quick and intensive treatment is necessary with high to very high doses of IVIG , corticosteroids, TENS unit read the electronic section. The stage and severity of the disease determines the duration and the dose of the medication. Sometimes immunosuppressives have to be added to the corticosteroid treatment. Mostly azathioprine (Imuran) is used in fairly high doses (up to 3mg/kg-body weight each day).
Prognosis
The prognosis has improved considerably the past few years. The most important reason for this is an early diagnosis and treatment. If the first flare is suppressed, a permanent remission is seen in 60% of the cases after 2 to 5 years.
Heredity
PM/DM is not hereditary,